The store will not work correctly when cookies are disabled.
1-{3-[4-(tert-butyl) phenyl]-5-N,N-dimethylaminomethyl-(1,2,4-triazol-4-yl)}-3-phenol
ID: ALA212375
PubChem CID: 11544824
Max Phase: Preclinical
Molecular Formula: C21H26N4O
Molecular Weight: 350.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)Cc1nnc(-c2ccc(C(C)(C)C)cc2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C21H26N4O/c1-21(2,3)16-11-9-15(10-12-16)20-23-22-19(14-24(4)5)25(20)17-7-6-8-18(26)13-17/h6-13,26H,14H2,1-5H3
Standard InChI Key: VARCIQVXDHUYNT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
6.4402 -0.7416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4391 -1.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1539 -1.9819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8703 -1.5685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8675 -0.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1521 -0.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1501 0.4961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8161 0.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5588 1.7669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7338 1.7644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4813 0.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7543 0.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0579 1.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3270 0.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2912 -0.1631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9925 -0.6058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7206 -0.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5855 -1.9799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6015 0.7304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2129 1.2843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9983 1.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0390 2.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5603 -0.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8635 -0.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5261 -1.3699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8417 -0.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
7 8 1 0
13 14 1 0
1 2 2 0
14 15 2 0
3 4 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 12 1 0
4 5 1 0
4 18 1 0
2 3 1 0
8 19 1 0
8 9 2 0
19 20 1 0
9 10 1 0
20 21 1 0
10 11 2 0
20 22 1 0
11 7 1 0
15 23 1 0
6 7 1 0
23 24 1 0
5 6 2 0
23 25 1 0
6 1 1 0
23 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.47 | Molecular Weight (Monoisotopic): 350.2107 | AlogP: 4.00 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.01 | CX Basic pKa: 6.74 | CX LogP: 4.06 | CX LogD: 3.97 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.77 | Np Likeness Score: -1.47 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |
2. Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ.. (2009) Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways., 17 (17): [PMID:19646882] [10.1016/j.bmc.2009.07.007] |